|
|
|
Volumn 6, Issue 12, 2008, Pages 899-909
|
|
Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategies.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
RITUXIMAB;
ANIMAL;
B LYMPHOCYTE;
CYTOGENETICS;
DRUG THERAPY;
HUMAN;
IMMUNOBLASTIC LYMPHADENOPATHY;
IMMUNOLOGY;
PATHOLOGY;
PATHOPHYSIOLOGY;
PERIPHERAL T CELL LYMPHOMA;
REVIEW;
T LYMPHOCYTE;
TRANSPLANTATION;
VIRUS INFECTION;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
B-LYMPHOCYTES;
CYCLOSPORINE;
CYTOGENETICS;
DRUG THERAPY;
EPSTEIN-BARR VIRUS INFECTIONS;
HUMANS;
IMMUNOBLASTIC LYMPHADENOPATHY;
IMMUNOSUPPRESSIVE AGENTS;
LYMPHOMA, T-CELL, PERIPHERAL;
T-LYMPHOCYTES;
TRANSPLANTATION;
|
|
EID: 64949199698
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (33)
|
|
References (100)
|
